A Study on Using Computer Technology (AI) to Evaluate Sperm Health in Men

Assessing The Acrosome Intactness Using Immunoflouroscene by an Al (Artificial Intelligence) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108468

Enrollment

Registered

2026-04-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N99- Intraoperative and postproceduralcomplications and disorders of genitourinary system, not elsewhere classified

Interventions

Intervention1: AI-based application for acrosome assessment: application is used to assess acrosome stability when we upload microscopy slide images of sperm from patient for a period of 5 minutes. Co

Eligibility

Inclusion criteria

Inclusion criteria: Male patients providing semen samples,Age more than 18 years,Patients undergoing fertility evaluation,Willing to give consent

Exclusion criteria

Exclusion criteria: Poor quality samples (insufficient sperm count),Patients unwilling to participate,Samples not suitable for analysis

Design outcomes

Primary

Measure	Time frame
Accuracy of AI-based application in detecting acrosome intactness Timepoint: Baseline	—

Secondary

Measure	Time frame
Time taken for analysis (AI vs manual),Agreement between AI & manual method (Kappa statistic),Feasibility of AI application in clinical practiceTimepoint: baseline	—

Countries

India

Contacts

Public ContactDr Rownika

Saveetha medical college hospital

nidhisharma.smc@saveetha.com9445560392

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026